IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-WAOfficial filing linked

Dan Newhouse disclosed BUY $ELV

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2024-04-10
Trade date
2024-04-10
Disclosure lag
Same-day filing

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared same-day filing, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
43 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Dan Newhouse, but PoliWealth treats it as context - not proof of intent or wrongdoing.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20024917 · filed 2024-04-10 · disclosed 0d after transaction

Market context

Elevance Health, Inc. Common Stock

Factual flags

  • 3 nearby same-ticker disclosures in the surrounding 30-day window.
  • 31 trades filed on 2024-04-10 (batch dump)

Member trail

Dan Newhouse

U.S. House · WA-4

House Committee on AgricultureHouse Committee on AppropriationsHouse Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party

Ticker trail

$ELV

Company metadata pending

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.